Bunge Global SA Files 8-K
Ticker: BG · Form: 8-K · Filed: 2025-07-08T00:00:00.000Z
Sentiment: neutral
Topics: regulatory-filing, sec-filing
TL;DR
Bunge Global SA filed a routine 8-K on 7/8/25, no major news.
AI Summary
Bunge Global SA filed an 8-K on July 8, 2025, reporting other events and financial statements. The filing provides no specific details on new events or financial figures, but confirms the company's reporting status.
Why It Matters
This filing indicates Bunge Global SA is meeting its regulatory reporting obligations with the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — This is a standard regulatory filing with no new material information disclosed.
Key Players & Entities
- Bunge Global SA (company) — Registrant
- July 8, 2025 (date) — Date of Report
- 000-56607 (company) — SEC File Number
- Route de Florissant 13, 1206 Geneva, Switzerland (company) — Principal Executive Offices
- 1391 Timberlake Manor Parkway Chesterfield, MO 63017 (company) — Corporate Headquarters
FAQ
What specific events are being reported in this 8-K filing?
The filing indicates 'Other Events' and 'Financial Statements and Exhibits' as items, but does not specify the nature of these events or statements.
What is the exact date of the earliest event reported?
The date of the earliest event reported is July 8, 2025.
What is Bunge Global SA's state of incorporation?
Bunge Global SA is incorporated in Switzerland.
What is the SEC file number for Bunge Global SA?
The SEC file number for Bunge Global SA is 000-56607.
Where are Bunge Global SA's principal executive offices located?
Bunge Global SA's principal executive offices are located at Route de Florissant 13, 1206 Geneva, Switzerland.
From the Filing
0001996862-25-000192.txt : 20250708 0001996862-25-000192.hdr.sgml : 20250708 20250708163246 ACCESSION NUMBER: 0001996862-25-000192 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250708 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250708 DATE AS OF CHANGE: 20250708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bunge Global SA CENTRAL INDEX KEY: 0001996862 STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070] ORGANIZATION NAME: 04 Manufacturing EIN: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-56607 FILM NUMBER: 251111372 BUSINESS ADDRESS: STREET 1: ROUTE DE FLORISSANT 13 CITY: GENEVA STATE: V8 ZIP: 1206 BUSINESS PHONE: 41 22 592 91 00 MAIL ADDRESS: STREET 1: ROUTE DE FLORISSANT 13 CITY: GENEVA STATE: V8 ZIP: 1206 8-K 1 bg-20250708.htm 8-K bg-20250708 0001996862 false 0001996862 2025-07-08 2025-07-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 8, 2025 Date of Report (date of earliest event reported) ___________________________________ BUNGE GLOBAL SA (Exact name of registrant as specified in its charter) ___________________________________ Switzerland (State of Incorporation) 000-56607 (Commission File Number) 98-1743397 (IRS Employer Identification Number) Route de Florissant 13 , 1206 Geneva , Switzerland N.A. (Address of principal executive offices and zip code) (Zip Code) 1391 Timberlake Manor Parkway Chesterfield, MO  63017 (Address of corporate headquarters ) (Zip Code) ( 314 ) 292-2000 (Registrant's telephone number, including area code) N.A. (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Registered Shares, $0.01 par value per share BG New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01 Other Events Exchange Offers and Consent Solicitations On July 8, 2025, Bunge Limited Finance Corp. (“BLFC”), the wholly-owned subsidiary of Bunge Global SA (“Bunge”), completed its previously announced (i) offers to exchange (collectively, the “Exchange Offers”) any and all outstanding 2.000% Notes due 2026 (the “Existing Viterra 2026 Notes”), 4.900% Notes due 2027 (the “Existing Viterra 2027 Notes”), 3.200% Notes due 2031 (the “Existing Viterra 2031 Notes”), and 5.250% Notes due 2032 (the “Existing Viterra 2032 Notes”, and with the Existing Viterra 2026 Notes, the Existing Viterra 2027 Notes and the Existi